How Does Cialis Work in the Body

Chemical Composition, Mechanism of Action & Metabolic Effects Explained

Key Takeaways: How Cialis (Tadalafil) Works

  • Primary Action: Selective inhibition of phosphodiesterase type 5 (PDE5) enzyme
  • Chemical Effect: Increases cyclic guanosine monophosphate (cGMP) levels in penile tissue
  • Physiological Result: Relaxes smooth muscle in penile arteries, enhancing blood flow
  • Unique Duration: Effects last up to 36 hours – the longest among PDE5 inhibitors
  • Onset: Can be taken at least 30 minutes before sexual activity; peak effect around 2 hours
  • Requires Stimulation: Sexual arousal is essential to trigger nitric oxide release

Sildenafil (Viagra) works by a similar mechanism – inhibiting PDE5 – but with a shorter duration of action (4‑6 hours) and different chemical structure. While sildenafil is taken on demand, tadalafil offers a longer window of effectiveness.

Important Medical Advice

If you experience chest pain, an erection lasting more than 4 hours (priapism), sudden vision loss, or sudden hearing decrease while taking Cialis, seek immediate medical attention. Do not take Cialis with nitrates (e.g., for chest pain) as this can cause a dangerous drop in blood pressure.

Chemical Composition & Molecular Structure of Tadalafil

Tadalafil, the active ingredient in Cialis, is a selective PDE5 inhibitor with a distinct molecular structure that contributes to its long half‑life.

Chemical Structure Details

Chemical Name

(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione

This complex heterocyclic structure gives tadalafil its high selectivity for PDE5.

Molecular Formula

C22H19N3O4

22 carbon, 19 hydrogen, 3 nitrogen, and 4 oxygen atoms.

Molecular Weight

389.4 g/mol

Relatively low molecular weight facilitates good tissue penetration.

Key Pharmaceutical Properties

PropertyValue/CharacteristicClinical Significance
SolubilityPractically insoluble in water; soluble in organic solventsFormulation uses lactose and other excipients to aid absorption
Protein Binding94% bound to plasma proteinsHigh binding affects distribution and drug interactions
SelectivityPDE5 vs PDE6 > 900‑fold selectiveVery low risk of visual side effects compared to sildenafil

🗒️ Pharmaceutical Insight: The unique ring structure of tadalafil, particularly the methylenedioxyphenyl group, contributes to its prolonged half‑life (17.5 hours) and high selectivity for PDE5 over other phosphodiesterases.

Mechanism of Action: How Tadalafil Creates an Erection

Tadalafil enhances the natural erectile response by amplifying the NO‑cGMP pathway.

The Normal Erection Pathway

  1. Sexual Stimulation: Nerves release nitric oxide (NO) in the penis.
  2. Enzyme Activation: NO activates guanylate cyclase.
  3. cGMP Production: Guanylate cyclase produces cyclic GMP.
  4. Smooth Muscle Relaxation: cGMP causes relaxation of penile arteries and corpus cavernosum.
  5. Increased Blood Flow: Blood flows in, creating an erection.
  6. Natural Breakdown: PDE5 enzyme normally breaks down cGMP, ending the erection.

Tadalafil's Intervention

StepNormal ProcessTadalafil Effect
1. NO ReleaseSexual stimulation triggers NO releaseTadalafil does not affect this step – requires natural stimulation
2. cGMP ProductionGuanylate cyclase produces cGMPNormal production continues unaffected
3. PDE5 ActionPDE5 breaks down cGMP, limiting erection durationTadalafil blocks PDE5, preventing cGMP breakdown
4. ResultLimited cGMP leads to weaker/shorter erectionsEnhanced cGMP levels support stronger, longer‑lasting erections (up to 36h)

🗒️ Physiological Insight: Tadalafil does not cause an erection on its own – sexual stimulation is essential. It simply prolongs the natural signal.

Enzyme Inhibition: Targeting Phosphodiesterase Type 5

Tadalafil is a highly selective, reversible inhibitor of PDE5, the enzyme responsible for cGMP degradation in the corpus cavernosum.

Inhibition Characteristics

Inhibition Type

Competitive Reversible Inhibition

Tadalafil competes with cGMP for the active site of PDE5.

Binding Affinity

IC50 = 0.9 nM (very high affinity)

Strong binding even at low concentrations.

Selectivity

>900‑fold selective for PDE5 over PDE6

Explains minimal visual side effects.

Selectivity Profile

PDE EnzymeTissue LocationTadalafil SelectivityClinical Relevance
PDE5Penis, lungs, blood vesselsPrimary target (IC50 0.9 nM)Erectile dysfunction treatment
PDE6Retina>900‑fold less potentVery rare visual effects
PDE11Skeletal muscle, testesModerate affinity (IC50 37 nM)May contribute to back pain / myalgia

🗒️ Biochemical Insight: Tadalafil’s selectivity for PDE5 over PDE6 is much higher than sildenafil’s, which is why colour‑vision disturbances are less common with Cialis.

Metabolic Effects and Duration in the Body

Tadalafil is metabolised primarily in the liver and has a distinctive long half‑life.

Metabolic Pathway

Primary Metabolism

Location: Liver (mainly CYP3A4)

Process: Oxidation to catechol metabolites

Result: Major metabolite is inactive

Secondary Metabolism

Enzymes: CYP2C9, CYP2C19 minor roles

Process: Glucuronidation and methylation

Result: Water‑soluble compounds for excretion

Elimination

Route: 61% faeces, 36% urine (mostly metabolites)

Half‑life: 17.5 hours in healthy adults

Duration of effect: Up to 36 hours

Timeline After a 10mg or 20mg Dose

  1. 0‑2 hours: Absorption; peak plasma concentration achieved.
  2. 2‑24 hours: Therapeutic levels maintained; PDE5 inhibited.
  3. 24‑36 hours: Gradual decline but still effective for many men.
  4. 36‑72 hours: Drug eliminated; effect subsides.

🗒️ Clinical Correlation: The long half‑life allows men to be less tied to timing – Cialis has been nicknamed the “weekend pill”. However, daily dosing (2.5mg or 5mg) is also available for continuous coverage.

Absorption, Distribution & Elimination of Tadalafil

Understanding pharmacokinetics helps explain why tadalafil works for up to 36 hours.

Pharmacokinetic Profile

Absorption

Bioavailability: Not determined (absolute); rapid absorption

Peak time (Tmax): 2 hours (range 30 min – 6 h)

Food effect: No clinically relevant delay; can be taken with or without food

Distribution

Volume of distribution: ~63 L

Protein binding: 94% (albumin, α1‑acid glycoprotein)

Tissue penetration: Good in penile tissue

Elimination

Half‑life: 17.5 hours

Clearance: 2.5 L/h (low clearance)

Excretion: Faeces (61%) and urine (36%) as metabolites

Special Population Considerations

PopulationEffect on TadalafilDosing Consideration
Elderly (≥65 years)25% higher AUCNo adjustment needed, but monitor tolerability
Renal impairment (severe)AUC doubled, T½ prolongedMaximum dose 10mg once daily (on‑demand) or 5mg daily
Hepatic impairment (moderate/severe)Exposure increased, limited dataMaximum 10mg once daily; avoid severe impairment
CYP3A4 inhibitors (e.g., ketoconazole)AUC increased up to 312%Maximum 10mg once every 72 hours

🗒️ Clinical Warning: Because tadalafil is metabolised mainly by CYP3A4, strong inhibitors (ritonavir, ketoconazole) can significantly raise levels. Always inform your doctor about all medications you take.

Clinical Efficacy for Erectile Dysfunction

Clinical studies demonstrate that tadalafil improves erection hardness and success rates of sexual intercourse.

Efficacy Data

ED Type/CauseTadalafil Efficacy RateStudy Details
General ED population81% improved erections (vs 35% placebo)Pooled analysis of 10mg/20mg on‑demand
Diabetes‑related ED64% successful intercourse attemptsSignificant improvement over placebo
Post‑radical prostatectomy~50% response (nerve‑sparing surgery)Lower if nerves damaged
Daily dosing (5mg)Similar efficacy to on‑demand, allows spontaneityPreferred by some couples

Optimal Use Based on Mechanism

  1. Timing: Take at least 30 minutes before sexual activity; effect lasts 36h.
  2. Dose: Start with 10mg, adjust to 20mg or 5mg daily based on response.
  3. Stimulation: Sexual arousal essential – tadalafil does not work without it.
  4. Frequency: Maximum once daily for on‑demand dosing; daily 5mg once daily.
  5. Contraindications: Nitrates, riociguat, severe heart disease, recent stroke/MI.

🗒️ Prescribing Insight: Men often prefer tadalafil for its long window, reducing the need to plan intercourse around medication timing. Daily dosing may also benefit men with frequent sexual activity.

Cialis Mechanism FAQs

No. Cialis only works when you are sexually aroused. It enhances the natural response to stimulation, it does not create an automatic erection.

The half‑life of tadalafil is about 17.5 hours, so it can be detected in the body for 5‑6 days. However, its clinical effect for erections lasts up to 36 hours.

Very rarely. Because tadalafil is >900‑fold selective for PDE5 over PDE6 (retinal enzyme), colour‑tinged vision is much less common than with sildenafil. If you experience sudden vision loss, stop and seek urgent care.

Back pain and muscle aches are thought to be related to mild inhibition of PDE11 in skeletal muscle. The effect is usually mild and temporary, often improving with continued use.

Moderate alcohol (1‑2 units) is generally safe. However, excessive drinking can impair erection and increase the risk of dizziness or low blood pressure. Avoid binge drinking.

Need Treatment for Erectile Dysfunction?

If you’re considering Cialis, a confidential online consultation with a UK‑registered doctor can help determine if it’s right for you.

Secure Prescription & Next‑Day Delivery

MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors

Start Cialis Consultation
Nabeel M. - Medical Content Manager at Chemist Doctor
Authored byNabeel M.

Medical Content Manager

Nabeel is a co‑founder and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up‑to‑date.

Medical Doctor

Dr. Feroz is a GMC‑registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.

Usman Mir - Superintendent Pharmacist
Approved byUsman Mir

Medical Director

Usman is a co‑founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 14 February 2026

Next Review: 14 August 2026

Published on: 14 February 2026

Last Updated: 14 February 2026